ATEA PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.71 USD | +0.54% |
|
-0.27% | +21.64% |
Chart calendar Atea Pharmaceuticals, Inc.
537158490f6779a4d1e.UkkBQgJGNNSLZPm0BGOKQ7hNQP29ezutwnRvio2BCB0.F35SBW0OfprZNLDsdwy-DPAZFrD1NUHkhDdd2t_FQFlqI1E3UyJju_EXig~eca10fca49d7519b3ee88ecd261ae216
Upcoming events on Atea Pharmaceuticals, Inc.
Past events on Atea Pharmaceuticals, Inc.
| 28/02/2024 21:30 | Q4 2023 Earnings Call |
| 28/02/2024 21:05 | Q4 2023 Earnings Release |
| 10/01/2024 18:30 | JPMorgan Healthcare Conference |
| 29/11/2023 20:00 | Evercore ISI HealthCONx Conference |
| 15/11/2023 11:00 | Jefferies London Healthcare Conference |
| 10/11/2023 18:00 | American Association for the Study of Liver Diseases Conference - Poster Number: 1861-A |
| 10/11/2023 18:00 | American Association for the Study of Liver Diseases Conference - Poster Number: 1879-A |
| 10/11/2023 18:00 | American Association for the Study of Liver Diseases Conference - Poster Number: 1861-A |
| 08/11/2023 21:30 | Q3 2023 Earnings Call |
| 08/11/2023 21:05 | Q3 2023 Earnings Release |
| 13/09/2023 15:10 | Morgan Stanley Global Healthcare Conference |
| 08/08/2023 21:30 | Q2 2023 Earnings Call |
| 08/08/2023 21:05 | Q2 2023 Earnings Release |
| 16/06/2023 14:00 | Annual General Meeting |
| 08/06/2023 19:00 | Jefferies Global Healthcare Conference |
| 08/05/2023 21:30 | Q1 2023 Earnings Call |
| 08/05/2023 21:05 | Q1 2023 Earnings Release |
| 17/04/2023 11:00 | European Congress of Clinical Microbiology & Infectious Diseases Conference - Poster Number: P2941 |
| 17/04/2023 11:00 | European Congress of Clinical Microbiology & Infectious Diseases Conference - Poster Number: P2629 |
| 16/03/2023 16:20 | Antiviral Research International Conference - Oral Presentation #047 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 48,6 147 -66.84% | 351 259 35.65% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -11,0 68,8 -116.01% | 138 57,4 141.25% | -130 -115 -13.43% | -164 -138 -18.24% | -210 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -11,0 54,9 -120.1% | 138 87,5 58.11% | -131 -119 -10.14% | -164 -146 -12.06% | -213 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -10,9 -62,0 82.34% | 139 65,6 111.38% | -119 -121 1.03% | -135 -138 1.92% | -231 |
|
Net income Million USD | Released Forecast Spread | -14,0 | -10,9 -62,4 82.47% | 121 20,0 506.36% | -116 -120 3.61% | -136 -138 1.63% | -231 |
|
EPS USD | Released Forecast Spread | -1,39 | -0,51 -1,45 64.91% | 1,37 0,21 542.8% | -1,39 -1,43 2.63% | -1,63 -1,66 1.61% | -2,76 |
| Announcement Date | 19/06/20 | 30/03/21 | 28/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 192 85,7 124.18% | 0,00 3,33 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 121 -34,0 456.44% | -42,2 -73,0 42.24% | -32,3 -47,0 31.38% | -16,2 -37,0 56.28% | -39,8 -44,0 9.56% | -41,5 -51,0 18.7% | -35,1 -52,0 32.44% | -40,7 -49,0 16.98% | -46,5 -50,0 7.06% | -59,0 | -70,0 | -75,0 | -79,0 |
|
EBIT Million USD | Released Forecast Spread | 121 48,4 150.58% | -42,2 -54,9 23.14% | -32,3 -45,1 28.37% | -16,3 -36,1 54.96% | -39,9 -39,6 -0.65% | -41,6 -46,6 10.75% | -35,2 -47,8 26.26% | -40,8 -44,1 7.55% | -46,6 -47,4 1.73% | -54,6 | -62,2 | -65,1 | -68,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 121 48,4 150.55% | -42,1 -54,9 23.29% | -31,2 -45,1 30.74% | -11,9 -35,1 66.13% | -34,3 -35,6 3.75% | -35,3 -42,0 15.99% | -27,9 -41,7 32.99% | -32,9 -37,9 13.09% | -38,8 -41,5 6.5% | -49,5 | -57,5 | -60,5 | -63,9 |
|
Net income Million USD | Released Forecast Spread | 117 15,9 638.07% | -42,1 -46,4 9.32% | -31,3 -43,4 27.88% | -8,07 -37,1 78.25% | -34,4 -37,6 8.5% | -35,5 -41,8 15.13% | -28,2 -40,5 30.39% | -33,1 -39,9 16.98% | -39,2 -41,3 5.27% | -50,7 | -57,3 | -59,7 | -63,3 |
|
EPS USD | Released Forecast Spread | 1,32 0,38 247.59% | -0,51 -0,56 8.15% | -0,38 -0,52 27.23% | -0,10 -0,44 77.43% | -0,41 -0,45 9.03% | -0,43 -0,50 14.56% | -0,34 -0,49 30.11% | -0,40 -0,48 16.07% | -0,47 -0,50 5.37% | -0,61 | -0,68 | -0,71 | -0,76 |
| Announcement Date | 28/02/22 | 10/05/22 | 08/08/22 | 07/11/22 | 28/02/23 | 08/05/23 | 08/08/23 | 08/11/23 | 28/02/24 | - | - | - | - |
More events
Past sector events for Atea Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AVIR Stock
- Calendar Atea Pharmaceuticals, Inc.
